No image

ARK™ Topiramate Assay

The ARK™ Topiramate Assay is a homogeneous enzyme immunoassay intended for the quantitative determination of topiramate in human serum or plasma on automated clinical chemistry analyzers. The results obtained are used in the diagnosis and treatment of topiramate overdose and in monitoring levels of topiramate to help ensure appropriate therapy.

Details

Device typeMultiple-therapy therapeutic drug monitoring IVD, kit, enzyme immunoassay (EIA): A collection of reagents and other associated materials intended to be used for the quantitative measurement and therapeutic monitoring of multiple drugs used for different types of therapies (e.g., antibiotic, anticonvulsant, and cardiovascular) in a clinical specimen, using an enzyme immunoassay (EIA) method.

FDA categoryImmunoassay, Anti-Seizure Drug

Device ID00858724003001

Catalog number5015-0001-00

AvailabilityPrescription

Single useYes

MRI safetyLabeling does not contain MRI Safety Information

Contact

Phone5102706270

Emailcustomersupport@ark-tdm.com

Related products

Product	Model	Company	Device type
ARK™ Lamotrigine AssayArk Diagnostics IncMultiple anticonvulsant therapeutic drug monitoring IVD, reagent	5023-0001-00	Ark Diagnostics Inc	Multiple anticonvulsant therapeutic drug monitoring IVD, reagent
ARK™ Oxcarbazepine Metabolite AssayArk Diagnostics IncMultiple anticonvulsant therapeutic drug monitoring IVD, reagent	5032-0001-00	Ark Diagnostics Inc	Multiple anticonvulsant therapeutic drug monitoring IVD, reagent
ARK™ Levetiracetam AssayArk Diagnostics IncLevetiracetam therapeutic drug monitoring IVD, reagent	5024-0001-00	Ark Diagnostics Inc	Levetiracetam therapeutic drug monitoring IVD, reagent
ARK™ Pregabalin II AssayArk Diagnostics IncMultiple anticonvulsant therapeutic drug monitoring IVD, reagent	5059-0001-01	Ark Diagnostics Inc	Multiple anticonvulsant therapeutic drug monitoring IVD, reagent